505 filings
Page 9 of 26
8-K
p4soauu0xltv87
21 May 19
Entry into a Material Definitive Agreement
5:22pm
8-K
hdn v0f071h2xgh8r
17 May 19
Submission of Matters to a Vote of Security Holders
5:16pm
8-K
dfyhlhoeql7 pi
16 May 19
Departure of Directors or Certain Officers
9:32pm
8-K
lo0qq6w3wp sp6
9 May 19
Cytokinetics Reports First Quarter 2019 Financial Results
4:01pm
8-K
pyxxanc8j1u fjx2h
6 May 19
Other Events
2:44pm
8-K
t4xv ap1d
20 Mar 19
Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis
8:30am
8-K
u87a0jb 9gxhy3vfdj
4 Mar 19
Departure of Directors or Certain Officers
4:15pm
8-K
w2rih j36
21 Feb 19
Cytokinetics Reports Fourth Quarter 2018 Financial Results
4:07pm
8-K
4lvi0 vbawc
21 Feb 19
Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
8:30am
8-K
azt nnw4ex1
20 Feb 19
Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator
9:00am
8-K
lal 9mzshd3
18 Jan 19
Departure of Directors or Certain Officers
5:00pm
8-K
nmvfaay0la ll
10 Dec 18
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND
9:05am
8-K
0w7gojb0mx0xkzg5e
6 Dec 18
Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274, a Cardiac Myosin Inhibitor
6:05am
8-K
1czrx3nurh
27 Nov 18
Cytokinetics Completes Enrollment in FORTITUDE-ALS, Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS
8:27am
8-K
fitujmfl33ltf
1 Nov 18
Cytokinetics, Inc. Reports Third Quarter 2018 Financial Results
4:00pm
8-K
fxlo1foo1b
16 Oct 18
Cytokinetics Unveils Expanded Development Pipeline and Provides Key Updates on Late-Stage Clinical Research Programs at R&D Day
7:30am
8-K
x2pdni od3
5 Oct 18
Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
7:30am
8-K
dkx6yc ic0ih9ia4wc
10 Aug 18
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:15pm
8-K
3lb3ot5vw7p16s3
26 Jul 18
Cytokinetics, Inc. Reports Second Quarter 2018 Financial Results
4:01pm
8-K
yct7ksrh8u6
18 Jun 18
Other Events
6:01am